2024-03-29T06:03:48Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_C338CC40D7D4
2024-03-23T02:56:35Z
serval:BIB_C338CC40D7D4
The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase.
10.1016/j.cell.2019.07.031
31398338
Sanghvi
V.R.
author
Leibold
J.
author
Mina
M.
author
Mohan
P.
author
Berishaj
M.
author
Li
Z.
author
Miele
M.M.
author
Lailler
N.
author
Zhao
C.
author
de Stanchina
E.
author
Viale
A.
author
Akkari
L.
author
Lowe
S.W.
author
Ciriello
G.
author
Hendrickson
R.C.
author
Wendel
H.G.
author
article
2019-08-08
Cell
1097-4172
0092-8674
journal
178
4
807-819.e21
EGFR
FN3K
KEAP1
NRF2
de-glycation
fructosamine
glucose
glycation
hepatocellular carcinoma
redox
eng
60_published
peer-reviewed
Publication types: Journal Article
Publication Status: ppublish